GOALS & OBJECTIVES
Understanding, Preventing, And Managing COPD
Paper Symposium
Activity Date: December 2004  — Activity Info: Volume4, (10A)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

GOAL
To provide primary care physicians and pulmonary disease specialists with information on recognizing, diagnosing, and treating chronic obstructive pulmonary disease (COPD).

TARGET AUDIENCE
This activity is designed for primary care physicians and pulmonary disease specialists. No prerequisites required.

LEARNING OBJECTIVES
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy take responsibility for the content, quality, and scientific integrity of this CE activity. At the conclusion of this activity, participants should be able to:

  • Review the impact of COPD, both in the United States and globally.
  • Improve understanding of the pathophysiology of COPD, including the structural changes that occur in the parenchyma and the processes of hyperinflation and airway activity.
  • Assist healthcare providers in recognizing, diagnosing, and treating COPD.
  • Develop and implement strategies of COPD prevention.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Institute for Johns Hopkins Nursing is accredited by the American Nurses' Credentialing Center's Commission on Accreditation to provide continuing education for nurses. The University of Tennessee College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician's Recognition Award. The Institute for Johns Hopkins Nursing designates this educational activity for a maximum of 3 contact hours. This program is approved for 3 hours (0.3 CEUs) and is cosponsored by the University of Tennessee College of Pharmacy, which is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. A statement of CE credit will be mailed within 4 weeks of successful completion and evaluation of the program. ACPE program #064-999-04-250-H01.

Each participant should claim only those credits that he/she actually spent in the activity.

The estimated time to complete this educational activity: 3 hours.

Release date: November 15, 2004. Expiration date: November 15, 2006.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing, and the University of Tennessee College of Pharmacy names implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This program is supported by an educational grant from GlaxoSmithKline.

     
Home | Contact Us | View Account | Need Help?